Verhandel Johnson & Johnson met LHFX

Johnson & Johnson is a diversified healthcare giant operating across pharmaceuticals, medical devices, and consumer health. Its stock is driven by pharmaceutical pipeline developments, new drug approvals, medical device market trends, and litigation outcomes. It is considered a defensive blue-chip holding.